IMDX
Insight Molecular Diagnostics
IMDX
IMDX
22 hedge funds and large institutions have $11.5M invested in Insight Molecular Diagnostics in 2018 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
60% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 5
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Holders
22
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$6.9K | |
| 2 | +$3K | |
| 3 | +$2K | |
| 4 |
Morgan Stanley
New York
|
+$306 |
Top Sellers
| 1 | -$375K | |
| 2 | -$145K | |
| 3 | -$114K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$96K |
| 5 |
Millennium Management
New York
|
-$79K |